Biotech firm welcomes new leadership

TAMPA — M2Gen, a Tampa-based health informatics company specializing in the advancement of personalized medicine, has named Dr. William Dalton executive chairman and Timothy Wright president and CEO.

Dalton founded M2Gen - a for-profit subsidiary of Tampa-based Moffitt Cancer Center - in 2012 and had served as CEO since the company's inception. In his new role as executive chairman of the M2Gen board of directors, he will focus on promoting the science and vision of M2Gen and growth of the Oncology Research Information Exchange Network (ORIEN), an alliance of 16 U.S. cancer centers.

As Dalton's successor, Wright will assume financial and operational leadership of M2Gen, helping the organization expand its business portfolio. He brings more than 30 years experience in the pharmaceutical and biotech industries to the role, having served most recently as executive vice president of business development, strategy and commercial innovation at TEVA Pharmaceutical Industries Ltd. Wright has also held executive roles at pharmaceutical companies Covidien and Elan, according to a news release.

“M2Gen has seen considerable growth in the last year,” Dalton stated in the release. “It now manages ORIEN, the world's largest cancer-focused data warehouse linking clinical and molecular data, and the ORIEN Avatar Research Program, a partnership with pharmaceutical companies aimed at accelerating the discovery and development of novel cancer therapies.

“This leadership change will allow M2Gen to focus on expanding ORIEN while also enhancing its brand and services in the personalized medicine field,” he adds.